Library of Slides and Posters HV and AIDS Articles

HIV and AIDS Articles
HAART Has Clinical Benefits Even if Treatment Is Started Late, CD4 Cell Count Remains Low, and Viral Load Is Not Fully Suppressed Second-line Regimens Twice as Likely to Fail as Initial Therapy People Who Start HAART with a Higher CD4 Count Are More Likely to Achieve Complete Immune Recovery Atripla Users May Be Able to Take Weekend Treatment Breaks Treatment Interruption May Be Appropriate for Selected Adults and Children with HIV if CD4 Count is Maintained at a High Level Modern HAART Is Associated with Better Adherence and Greater Efficacy than Older Regimens Excellent Response with a PI- and NRTI-sparing Regimen of Raltegravir (Isentress), Maraviroc (Selzentry), and Etravirine (Intelence) Adherence, Pharmacokinetics, and Metabolic Changes in Treatment-naive Patients Receiving Once-daily or Twice-daily Lopinavir/ritonavir (Kaletra): Study M05-730 Biomarkers of Inflammation and Coagulation in Children and Adolescents with HIV
Library of Slides and Posters
Metabolic Evaluation of Study M05-730 through Week (Wk) 48: Phase 3, Randomized, Open- Label Study of Lopinavir/ritonavir (LPV/r) Tablets Once Daily (QD) versus Twice Daily (BID), Co- Administered with Tenofovir DF (TDF) + Emtricitabine (FTC) in Antiretroviral-Naïve (ARV) HIV-1 Infected Subjects B Da Silva and others. HIV9, Glasgow, UK. Population Pharmacokinetic/Pharmacodynamic Analyses of Lopinavir and Ritonavir in Subjects Receiving the Tablet Formulation C Klein and others. HIV9, Glasgow, UK. The Effect of Food on Ritonavir Bioavailability Following Administration of Ritonavir 100 mg Film-Coated Tablet in Healthy Adult Subjects C Klein and others. HIV9, Glasgow, UK. Adherence with Lopinavir/ritonavir (LPV/r) Tablet and Soft-Gel Capsule (SGC)-Based Antiretroviral Regimens and Predictors of Early Treatment Compliance R Rode and others. HIV9, Glasgow, UK. Efficacy and Safety by Baseline HIV RNA and CD4 Count in Treatment-Naïve Patients Treated With Atazanavir/RTV and Lopinavir/RTV in the CASTLE Study J Uy and others. HIV9, Glasgow, UK.

HIV9 Coverage

HIV9 Conference Coverage

HIV9 Coverage

HIV9 Conference Coverage

HIV9 Coverage

HIV9 Conference Coverage

HIV9 Coverage

HIV9 Conference Coverage